Tobacco
Compare Stocks
2 / 10Stock Comparison
ISPR vs XXII
Revenue, margins, valuation, and 5-year total return — side by side.
Tobacco
ISPR vs XXII — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Tobacco | Tobacco |
| Market Cap | $96M | $621K |
| Revenue (TTM) | $97M | $10M |
| Net Income (TTM) | $-36M | $-7M |
| Gross Margin | 16.3% | -34.3% |
| Operating Margin | -35.9% | -124.1% |
| Total Debt | $7M | $9M |
| Cash & Equiv. | $24M | $4M |
ISPR vs XXII — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 23 | May 26 | Return |
|---|---|---|---|
| Ispire Technology I… (ISPR) | 100 | 18.7 | -81.3% |
| 22nd Century Group,… (XXII) | 100 | 0.0 | -100.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ISPR vs XXII
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ISPR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.92
- Rev growth -16.1%, EPS growth -155.6%, 3Y rev CAGR 13.1%
- -77.7% 10Y total return vs XXII's -100.0%
XXII is the clearest fit if your priority is dividends and efficiency.
- 100.0% yield; 1-year raise streak; the other pay no meaningful dividend
- -27.8% ROA vs ISPR's -35.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -16.1% revenue growth vs XXII's -63.1% | |
| Quality / Margins | -36.6% margin vs XXII's -65.7% | |
| Stability / Safety | Beta 0.92 vs XXII's 1.60 | |
| Dividends | 100.0% yield; 1-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -41.1% vs XXII's -99.8% | |
| Efficiency (ROA) | -27.8% ROA vs ISPR's -35.6% |
ISPR vs XXII — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ISPR vs XXII — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ISPR leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISPR is the larger business by revenue, generating $97M annually — 9.4x XXII's $10M. ISPR is the more profitable business, keeping -36.6% of every revenue dollar as net income compared to XXII's -65.7%. On growth, XXII holds the edge at +59.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $97M | $10M |
| EBITDAEarnings before interest/tax | -$33M | -$12M |
| Net IncomeAfter-tax profit | -$36M | -$7M |
| Free Cash FlowCash after capex | -$25M | -$15M |
| Gross MarginGross profit ÷ Revenue | +16.3% | -34.3% |
| Operating MarginEBIT ÷ Revenue | -35.9% | -124.1% |
| Net MarginNet income ÷ Revenue | -36.6% | -65.7% |
| FCF MarginFCF ÷ Revenue | -25.9% | -144.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -51.5% | +59.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +14.3% | — |
Valuation Metrics
XXII leads this category, winning 2 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $96M | $621,210 |
| Enterprise ValueMkt cap + debt − cash | $79M | $5M |
| Trailing P/EPrice ÷ TTM EPS | -2.43x | — |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.75x | 0.05x |
| Price / BookPrice ÷ Book value/share | 157.95x | 0.15x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
XXII leads this category, winning 5 of 8 comparable metrics.
Profitability & Efficiency
XXII delivers a -79.2% return on equity — every $100 of shareholder capital generates $-79 in annual profit, vs $-24 for ISPR. XXII carries lower financial leverage with a 2.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to ISPR's 11.67x. On the Piotroski fundamental quality scale (0–9), XXII scores 6/9 vs ISPR's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -23.8% | -79.2% |
| ROA (TTM)Return on assets | -35.6% | -27.8% |
| ROICReturn on invested capital | — | -148.2% |
| ROCEReturn on capital employed | -114.1% | -196.8% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 |
| Debt / EquityFinancial leverage | 11.67x | 2.15x |
| Net DebtTotal debt minus cash | -$17M | $4M |
| Cash & Equiv.Liquid assets | $24M | $4M |
| Total DebtShort + long-term debt | $7M | $9M |
| Interest CoverageEBIT ÷ Interest expense | -50.34x | -7.56x |
Total Returns (Dividends Reinvested)
ISPR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISPR five years ago would be worth $2,225 today (with dividends reinvested), compared to $0 for XXII. Over the past 12 months, ISPR leads with a -41.1% total return vs XXII's -99.8%. The 3-year compound annual growth rate (CAGR) favors ISPR at -43.7% vs XXII's -99.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -41.3% | -93.6% |
| 1-Year ReturnPast 12 months | -41.1% | -99.8% |
| 3-Year ReturnCumulative with dividends | -82.1% | -100.0% |
| 5-Year ReturnCumulative with dividends | -77.7% | -100.0% |
| 10-Year ReturnCumulative with dividends | -77.7% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -43.7% | -99.0% |
Risk & Volatility
ISPR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ISPR is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than XXII's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ISPR currently trades 43.4% from its 52-week high vs XXII's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.92x | 1.60x |
| 52-Week HighHighest price in past year | $3.87 | $483.00 |
| 52-Week LowLowest price in past year | $1.20 | $0.67 |
| % of 52W HighCurrent price vs 52-week peak | +43.4% | +0.2% |
| RSI (14)Momentum oscillator 0–100 | 40.7 | 14.6 |
| Avg Volume (50D)Average daily shares traded | 112K | 1.4M |
Analyst Outlook
ISPR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
XXII is the only dividend payer here at 100.00% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | 1 | — |
| Dividend YieldAnnual dividend ÷ price | — | +100.0% |
| Dividend StreakConsecutive years of raises | 2 | 1 |
| Dividend / ShareAnnual DPS | — | $14.11 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% |
ISPR leads in 4 of 6 categories (Income & Cash Flow, Total Returns). XXII leads in 2 (Valuation Metrics, Profitability & Efficiency).
ISPR vs XXII: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ISPR or XXII a better buy right now?
For growth investors, Ispire Technology Inc.
(ISPR) is the stronger pick with -16. 1% revenue growth year-over-year, versus -63. 1% for 22nd Century Group, Inc. (XXII). Analysts rate Ispire Technology Inc. (ISPR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ISPR or XXII?
Over the past 5 years, Ispire Technology Inc.
(ISPR) delivered a total return of -77. 7%, compared to -100. 0% for 22nd Century Group, Inc. (XXII). Over 10 years, the gap is even starker: ISPR returned -77. 7% versus XXII's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ISPR or XXII?
By beta (market sensitivity over 5 years), Ispire Technology Inc.
(ISPR) is the lower-risk stock at 0. 92β versus 22nd Century Group, Inc. 's 1. 60β — meaning XXII is approximately 74% more volatile than ISPR relative to the S&P 500. On balance sheet safety, 22nd Century Group, Inc. (XXII) carries a lower debt/equity ratio of 2% versus 12% for Ispire Technology Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — ISPR or XXII?
By revenue growth (latest reported year), Ispire Technology Inc.
(ISPR) is pulling ahead at -16. 1% versus -63. 1% for 22nd Century Group, Inc. (XXII). Over a 3-year CAGR, ISPR leads at 13. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ISPR or XXII?
Ispire Technology Inc.
(ISPR) is the more profitable company, earning -30. 8% net margin versus -127. 7% for 22nd Century Group, Inc. — meaning it keeps -30. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISPR leads at -29. 7% versus -117. 4% for XXII. At the gross margin level — before operating expenses — ISPR leads at 17. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ISPR or XXII?
In this comparison, XXII (100.
0% yield) pays a dividend. ISPR does not pay a meaningful dividend and should not be held primarily for income.
07Is ISPR or XXII better for a retirement portfolio?
For long-horizon retirement investors, Ispire Technology Inc.
(ISPR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92)). 22nd Century Group, Inc. (XXII) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ISPR: -77. 7%, XXII: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ISPR and XXII?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ISPR is a small-cap quality compounder stock; XXII is a small-cap income-oriented stock. XXII pays a dividend while ISPR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Consumer Defensive
- Market Cap > $100B
- Revenue Growth > 29%
- Dividend Yield > 40.0%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.